• TickerA2DHZ4
  • ISINIT0001353140
  • SectorFinancial Services
  • CountryItaly

Analysts

Proxy Report - EGM - 6th of September 2016

​The EGM is called to approve the merger by incorporation of Exor SpA into its wholly-ownedDutch subsidiary Exor Holding NV. Through the transaction, Exor will change itscountry of incorporation from Italy to the Netherlands. The transaction is aimed atsimplifying the Group's structure, as 85% of Exor's investments are, or are indirectlyowned through, Dutch companies (i.e., Fiat Chrysler Automobiles, Ferrrari, CNHIndustrial and the global insurer PartnerRe Ltd, which is 100% held through Exor NV).Similarly to its listed subsidiaries, Exor will adopt a multiple-voting structure, granting 5votes...

Italian Chance

​Italy’s Exor has been reshaping PartnerRe after buying the company for about $6 billion this year. PartnerRe in August added Nikhil Srinivasan, chief investment officer of Assicurazioni Generali SpA, to its board as the company rearranges its investment portfolio, building property bets. Exor also controls Fiat Chrysler Automobiles NV and Ferrari NV and has said reinsurance offers an opportunity to diversify operations. We divide our report in 3 sectors:- Ratio summary- Peer group confrontation- Next 90/180 days share price movement forecasting using our proprietary “Evidence Based Performanc...

Louis-Clément AZAIS d'UHART

Short term view - EXOR SPA : The resistance has been passed.

Our previous opinion was neutral. We turn positive with a target at 42,82 € and an invalidation level at 34,66 €. The bullish trend resumes after the consolidation. Arguments : - The ascending support has been shortly breached, but it is now reinstated. Prices can rise. -...

Louis-Clément AZAIS d'UHART

Analyse court terme - EXOR SPA : La résistance est dépassée.

Notre précédent avis était neutre. Nous sommes maintenant positif avec un objectif à 42,82 € et un niveau d'invalidation à 34,66 €. La tendance haussière reprend après la consolidation. Arguments : - Le support ascendant a été enfoncé, mais il est réintégré. Les prix peuvent...

Matthieu DRIOL

Analyse moyen terme - EXOR SPA : Les prix dépassent la moyenne mobile, c'est un signal de force.

Le précédent sommet vient d'être franchi, ceci confirme la tendance haussière. Le prochain objectif est à 46,66 €. Le niveau d'invalidation est sous 34,07 €.Arguments :- Le support majeur est atteint, il cause le rebond.- Les prix dépassent la moyenne mobile, c'est un signal de...

Italian Chance

​Italy’s Exor has been reshaping PartnerRe after buying the company for about $6 billion this year. PartnerRe in August added Nikhil Srinivasan, chief investment officer of Assicurazioni Generali SpA, to its board as the company rearranges its investment portfolio, building property bets. Exor also controls Fiat Chrysler Automobiles NV and Ferrari NV and has said reinsurance offers an opportunity to diversify operations. We divide our report in 3 sectors:- Ratio summary- Peer group confrontation- Next 90/180 days share price movement forecasting using our proprietary “Evidence Based Performanc...

Proxy Report - EGM - 6th of September 2016

​The EGM is called to approve the merger by incorporation of Exor SpA into its wholly-ownedDutch subsidiary Exor Holding NV. Through the transaction, Exor will change itscountry of incorporation from Italy to the Netherlands. The transaction is aimed atsimplifying the Group's structure, as 85% of Exor's investments are, or are indirectlyowned through, Dutch companies (i.e., Fiat Chrysler Automobiles, Ferrrari, CNHIndustrial and the global insurer PartnerRe Ltd, which is 100% held through Exor NV).Similarly to its listed subsidiaries, Exor will adopt a multiple-voting structure, granting 5votes...

Louis-Clément AZAIS d'UHART

Short term view - EXOR SPA : The resistance has been passed.

Our previous opinion was neutral. We turn positive with a target at 42,82 € and an invalidation level at 34,66 €. The bullish trend resumes after the consolidation. Arguments : - The ascending support has been shortly breached, but it is now reinstated. Prices can rise. -...

Louis-Clément AZAIS d'UHART

Analyse court terme - EXOR SPA : La résistance est dépassée.

Notre précédent avis était neutre. Nous sommes maintenant positif avec un objectif à 42,82 € et un niveau d'invalidation à 34,66 €. La tendance haussière reprend après la consolidation. Arguments : - Le support ascendant a été enfoncé, mais il est réintégré. Les prix peuvent...

Matthieu DRIOL

Analyse moyen terme - EXOR SPA : Les prix dépassent la moyenne mobile, c'est un signal de force.

Le précédent sommet vient d'être franchi, ceci confirme la tendance haussière. Le prochain objectif est à 46,66 €. Le niveau d'invalidation est sous 34,07 €.Arguments :- Le support majeur est atteint, il cause le rebond.- Les prix dépassent la moyenne mobile, c'est un signal de...

Matthieu DRIOL

Medium term view - EXOR SPA : Prices are breaking above the moving average, it is a sign of strength.

The previous high has been passed, the bullish trend is confirmed. The next target is at €46.66. The invalidation level is below €34.07.Arguments :- The major support has been reached, it causes the bounce.- Prices are breaking above the moving average, it is a sign of strength.

Matthieu DRIOL

Medium term view - EXOR SPA : The resistance has been passed.

The previous high has been passed, the bullish trend is confirmed. The next target is at €67.60. The invalidation level is below €46.80.Arguments :- The resistance has been passed.- The moving average is supporting prices.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch